Guerbet

Guerbet: Guerbet announces a change in governance for its Artificial Intelligence projects

03 11 2022 13:04:18 提供 Nasdaq GlobeNewswire

Guerbet: Revenue at September 30, 2022

20 10 2022 11:45:00 提供 Nasdaq GlobeNewswire

Guerbet obtains one million euros of public funding from Bpifrance (France 2030 investment plan) for a project developing artificial intelligence for the early detection of pancreatic cancer

26 9 2022 12:00:00 提供 Nasdaq GlobeNewswire

Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)

21 9 2022 13:00:00 提供 Nasdaq GlobeNewswire

Guerbet: 2022 half-year results

21 9 2022 11:45:00 提供 Nasdaq GlobeNewswire

Guerbet: Revenue at June 30, 2022

21 7 2022 11:45:00 提供 Nasdaq GlobeNewswire

Guerbet receives EMA acceptance of EluciremTM as the Brand Name for Gadopiclenol

13 6 2022 02:30:00 提供 Nasdaq GlobeNewswire

Guerbet: Q1 2022 revenue

21 4 2022 11:45:00 提供 Nasdaq GlobeNewswire

Guerbet strengthens its Executive Committee with the appointment of Charlotte Bamière, General Counsel

06 4 2022 02:30:00 提供 Nasdaq GlobeNewswire

Guerbet - Gadopiclenol Marketing Authorization dossier submissions accepted for review by EMA and FDA - Priority Review granted by US-FDA March 28, 2022

29 3 2022 12:05:55 提供 Nasdaq GlobeNewswire

Guerbet: 2021 annual results

23 3 2022 12:45:00 提供 Nasdaq GlobeNewswire

Guerbet: Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolization

07 3 2022 12:00:48 提供 Nasdaq GlobeNewswire

Guerbet: 2021 revenue

10 2 2022 11:54:31 提供 Nasdaq GlobeNewswire

Guerbet: 2021 Corporate Social Responsibility Gaïa-Index: Guerbet consolidates its position as leader in the “Healthcare” category

04 1 2022 12:02:01 提供 Nasdaq GlobeNewswire

Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol

14 12 2021 01:00:00 提供 Nasdaq GlobeNewswire

Guerbet: Revenue at September 30, 2021

21 10 2021 11:46:04 提供 Nasdaq GlobeNewswire

Guerbet: Guerbet contributes to the NH TherAguix IPO on Euronext Growth, a specialist in innovative biotechnologies for precision radiotherapy

29 9 2021 12:00:54 提供 Nasdaq GlobeNewswire

Guerbet: 2021 half-year results

22 9 2021 11:54:05 提供 Nasdaq GlobeNewswire

Guerbet: Revenue at June 30, 2021

22 7 2021 11:46:33 提供 Nasdaq GlobeNewswire

Marc Massiot appointed to Guerbet’s Board of Directors

31 5 2021 12:00:00 提供 Nasdaq GlobeNewswire